RxDoctor Payments Data

Johnny Lindquist, MD

Urology · Greenville, SCNPI 1619406766

Payments from drug & device makers

$832in general payments, 2019–2025

Across 17 payments — averaging $48.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$570
  • Bayer$128
  • Coloplast$39
  • Blue Earth Diagnostics$35
  • AbbVie$26
  • Olympus America Inc.$19
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$832100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific10$570
Bayer1$128
Coloplast2$39
Blue Earth Diagnostics1$35
AbbVie1$26
Olympus America Inc.1$19
180 Medical, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$832 in reported general payments places this provider in the 25th percentile of 196 urology providers in South Carolina.

See all urology providers in South Carolina

Medicare billing

Part B allowed, 2024
$228,158
Medicare patients
492
Services billed
2,683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron25$14,322
Oxybutynin Chloride ErOxybutynin Chloride40$691
Tamsulosin Hcl104$544
Finasteride43$389
Bicalutamide17$364
Ciprofloxacin Hcl56$149
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim32$97

Paid to pharmacies, not to this prescriber.

Other urology in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →